Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Opinion in Pharmacology|November 25, 2016
Targeted therapy for breast cancer and molecular mechanisms of resistance to treatmentGuowei Gu, Derek Dustin, Suzanne Aw FuquaTranslational Research : the Journal of Laboratory and Clinical Medicine|April 2, 2016
Neuroimaging in Alzheimer's disease: preclinical challenges toward clinical efficacyDerek Dustin, Benjamin M Hall, Ananth Annapragada, et al.Chemical Communications (Cambridge, England)|June 12, 2015
Designed filamentous cell penetrating peptides: probing supramolecular structure-dependent membrane activity and transfection efficiencyDawei Xu, Derek Dustin, Linhai Jiang, et al.Chemical Communications (Cambridge, England)|April 1, 2014
Filamentous supramolecular peptide-drug conjugates as highly efficient drug delivery vehiclesMiao Yang, Dawei Xu, Linhai Jiang, et al.Hormones & Cancer|May 9, 2018
The Impact of ESR1 Mutations on the Treatment of Metastatic Breast CancerSasha M Pejerrey, Derek Dustin, Jin-Ah Kim, et al.Chemical Communications (Cambridge, England)|December 6, 2014
Designed supramolecular filamentous peptides: balance of nanostructure, cytotoxicity and antimicrobial activityDawei Xu, Linhai Jiang, Anju Singh, et al.Blood Advances|March 1, 2023
Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysisAshley Aaroe, Razelle Kurzrock, Gaurav Goyal, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2025
Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast CancerFoluso O Ademuyiwa, Cynthia X Ma, Katherine Weilbaecher, et al.British Journal of Cancer|December 1, 2020
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancerDerek Dustin, Guowei Gu, Amanda R Beyer, et al.Pageof 2